tirzepatide injection site itchy and red reaction treatment: evidence-based guide to relief Tirzepatide Injection Site Reaction Treatment:

Plant Cell Environ 29(5):10021011

Although gastrointestinal adverse events such as nausea, vomiting, and diarrhea were more frequent with tirzepatide, the overall findings suggest that dual GIP/GLP-1 receptor agonism may offer clinically meaningful renal advantages over selective GLP-1 receptor agonism alone

Overall, Ozempic lowered the risk of progression of patients kidney disease and of related health events by 24% versus placebo, according to the topline results

Kidney Function: Caution should be exercised when using Rybelsus in patients with renal impairment , as it may exacerbate kidney problems, especially in those with pre-existing kidney disease